Market Research Logo

Global TNF Inhibitors Market 2019-2023

Global TNF Inhibitors Market 2019-2023

About Tumor Necrosis Factor (TNF)

TNF is a cell signaling cytokine that is secreted by macrophages and plays a role in systemic inflammation, which is known to be the cause of various autoimmune diseases. TNF inhibitors are drugs that reverse the damage caused by these diseases.

Technavio’s analysts forecast the Global TNF Inhibitors Market to grow at a CAGR of 9.58% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the TNF inhibitors market. To calculate the market size, the report considers the revenue generated from the application of TNF inhibitors in healthcare across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, TNF inhibitors market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • UCB
  • Market driver

  • Increasing prevalence of autoimmune disorders
  • For a full, detailed list, view our report
Market challenge
  • Growing advent of biosimilars
  • For a full, detailed list, view our report
Market trend
  • Strategic alliances
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global TNF Inhibitors Market 2019-2023

Technavio recognizes the following companies as the key players in the global TNF inhibitors market: AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, and UCB.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the growing number of strategic alliances. At the present, biotech companies dominate the research area for drugs for tumor necrosis factor as they out-license the molecules or technology platforms to the bigger pharmaceutical companies.”

According to the report, one driver influencing this market is the increasing prevalence of autoimmune disorders across the globe. The rising incidences of tumor necrosis factor cancer and growing prevalence of various autoimmune disorders such as RA, psoriasis, and Chron’s disease is expected to fuel the demand for TNF immunology across the period of forecast.

Further, the report states that one challenge affecting this market is the growing advent of biosimilars. Vendors are increasingly focused on the development of biosimilars, which is expected to hinder the growth of the TNF inhibitors market.

Companies Mentioned

AbbVie
Amgen
Johnson & Johnson
Novartis
Pfizer
UCB

  • Executive summary
  • Scope of the report
  • Market landscape
    • Market ecosystem
      • Table Global autoimmune drugs market
      • Table Segments of global autoimmune drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Market segmentation by indication
    • Table Indication - Market share 2018-2023 (%)
    • Comparison by indication
      • Table Comparison by indication
    • TNF inhibitors for RA - Market size and forecast 2018-2023
      • Table TNF inhibitors for RA - Market size and forecast 2018-2023 ($ millions)
      • Table TNF inhibitors for RA - Year-over-year growth 2019-2023 (%)
      • Table TNF inhibitors for RA – Drivers and challenges
    • TNF inhibitors for psoriasis - Market size and forecast 2018- 2023
      • Table TNF inhibitors for psoriasis - Market size and forecast 2018-2023 ($ millions)
      • Table TNF inhibitors for psoriasis - Year-over-year growth 2019-2023 (%)
      • Table TNF inhibitors for psoriasis: Overview of market drivers and challenges
    • TNF inhibitors for IBD - Market size and forecast 2018-2023
      • Table TNF inhibitors for IBD - Market size and forecast 2018-2023 ($ millions)
      • Table TNF inhibitors for IBD - Year-over-year growth 2019-2023 (%)
      • Table TNF inhibitors for IBD: Overview of market drivers and challenges
    • Others - Market size and forecast 2018-2023
      • Table Others - Market size and forecast 2018-2023 ($ millions)
      • Table Others - Year-over-year growth 2019-2023 (%)
    • Market opportunity by indication
      • Table Market opportunity by indication
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Prevalence of arthritis in adults in the US
      • Table Growing geriatric population based on region
      • Table Percentage of geriatric population to the overall population
    • Market challenges
      • Table Impact of drivers and challenges
  • Market Trends
    • Table Patient assistance program by pharmaceutical companies
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie
      • Table AbbVie - Vendor overview
      • Table AbbVie - Business segments
      • Table AbbVie - Organizational developments
      • Table AbbVie – Geographic focus
      • Table AbbVie - Segment focus
      • Table AbbVie - Key offerings
      • Table AbbVie - Key customers
    • Amgen
      • Table Amgen - Vendor overview
      • Table Amgen - Business segments
      • Table Amgen - Organizational developments
      • Table Amgen – Geographic focus
      • Table Amgen - Segment focus
      • Table Amgen - Key offerings
      • Table Amgen - Key customers
    • Johnson & Johnson
      • Table Johnson & Johnson - Vendor overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson - Organizational developments
      • Table Johnson & Johnson – Geographic focus
      • Table Johnson & Johnson - Segment focus
      • Table Johnson & Johnson - Key offerings
      • Table Johnson & Johnson - Key customers
    • Novartis
      • Table Novartis - Vendor overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis – Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
      • Table Novartis - Key customers
    • Pfizer
      • Table Pfizer - Vendor overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer – Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
      • Table Pfizer - Key customers
    • UCB
      • Table UCB - Vendor overview
      • Table UCB - Business segments
      • Table UCB - Organizational developments
      • Table UCB – Geographic focus
      • Table UCB - Segment focus
      • Table UCB - Key offerings
      • Table UCB - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report